Log in

ChemoCentryx News Headlines (NASDAQ:CCXI)

$7.75
+0.48 (+6.60 %)
(As of 10/16/2019 08:00 AM ET)
Today's Range
$7.22
Now: $7.75
$7.86
50-Day Range
$6.53
MA: $7.12
$7.73
52-Week Range
$6.16
Now: $7.75
$14.98
Volume397,400 shs
Average Volume486,003 shs
Market Capitalization$449.89 million
P/E RatioN/A
Dividend YieldN/A
Beta1.15

Headlines

ChemoCentryx (NASDAQ CCXI) News Headlines

Source:
DateHeadline
ChemoCentryx Inc (NASDAQ:CCXI) Sees Significant Drop in Short InterestChemoCentryx Inc (NASDAQ:CCXI) Sees Significant Drop in Short Interest
www.americanbankingnews.com - October 15 at 12:56 PM
CCXI.OQ - ChemoCentryx Inc Profile | ReutersCCXI.OQ - ChemoCentryx Inc Profile | Reuters
www.reuters.com - October 3 at 10:17 PM
ChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Quarterly Sales of $8.20 MillionChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Quarterly Sales of $8.20 Million
www.americanbankingnews.com - October 3 at 10:38 AM
ChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Earnings of -$0.27 Per ShareChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Earnings of -$0.27 Per Share
www.americanbankingnews.com - October 1 at 1:51 PM
ChemoCentryx Inc (NASDAQ:CCXI) Given Average Recommendation of "Buy" by BrokeragesChemoCentryx Inc (NASDAQ:CCXI) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 25 at 11:31 AM
ChemoCentryx to Host R&D Day on October 1, 2019 - Yahoo FinanceChemoCentryx to Host R&D Day on October 1, 2019 - Yahoo Finance
finance.yahoo.com - September 24 at 10:24 PM
ChemoCentryx to Host R&D Day on October 1, 2019ChemoCentryx to Host R&D Day on October 1, 2019
feeds.benzinga.com - September 24 at 8:55 AM
ChemoCentryx: Fighting Steroids On Steroids - Seeking AlphaChemoCentryx: Fighting Steroids On Steroids - Seeking Alpha
seekingalpha.com - September 11 at 11:59 AM
ChemoCentryx to Present at Two Upcoming Investor Conferences - GlobeNewswireChemoCentryx to Present at Two Upcoming Investor Conferences - GlobeNewswire
www.globenewswire.com - August 29 at 8:17 PM
ChemoCentryx to Present at Two Upcoming Investor ConferencesChemoCentryx to Present at Two Upcoming Investor Conferences
finance.yahoo.com - August 29 at 8:17 PM
ChemoCentryx And InflaRx In Complement-Mediated Pathology: The Collateral Damage - Seeking AlphaChemoCentryx And InflaRx In Complement-Mediated Pathology: The Collateral Damage - Seeking Alpha
seekingalpha.com - August 27 at 8:30 AM
Microscopic Polyangiitis (MPA) Pipeline Review, H1 2019 Report Featuring Celltrion, ChemoCentryx, InflaRx, Teijin Pharma - ResearchAndMarkets.com - Business WireMicroscopic Polyangiitis (MPA) Pipeline Review, H1 2019 Report Featuring Celltrion, ChemoCentryx, InflaRx, Teijin Pharma - ResearchAndMarkets.com - Business Wire
www.businesswire.com - August 9 at 8:47 AM
ChemoCentryx Inc (CCXI) Q2 2019 Earnings Call Transcript - Yahoo FinanceChemoCentryx Inc (CCXI) Q2 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - August 9 at 8:47 AM
ChemoCentryx Inc (CCXI) Q2 2019 Earnings Call TranscriptChemoCentryx Inc (CCXI) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 8:47 AM
Edited Transcript of CCXI earnings conference call or presentation 5-Aug-19 9:00pm GMT - Yahoo FinanceEdited Transcript of CCXI earnings conference call or presentation 5-Aug-19 9:00pm GMT - Yahoo Finance
finance.yahoo.com - August 6 at 11:59 PM
ChemoCentryx down 16% after Q2 revenue miss - Seeking AlphaChemoCentryx down 16% after Q2 revenue miss - Seeking Alpha
seekingalpha.com - August 6 at 11:59 PM
Edited Transcript of CCXI earnings conference call or presentation 5-Aug-19 9:00pm GMTEdited Transcript of CCXI earnings conference call or presentation 5-Aug-19 9:00pm GMT
finance.yahoo.com - August 6 at 11:59 PM
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q2 2019 Results - Earnings Call Transcript - Seeking AlphaChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q2 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 5 at 11:44 PM
ChemoCentryx, Inc. 2019 Q2 - Results - Earnings Call Slides - Seeking AlphaChemoCentryx, Inc. 2019 Q2 - Results - Earnings Call Slides - Seeking Alpha
seekingalpha.com - August 5 at 11:44 PM
ChemoCentryx (CCXI) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceChemoCentryx (CCXI) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
finance.yahoo.com - August 5 at 11:44 PM
ChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights - GlobeNewswireChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights - GlobeNewswire
www.globenewswire.com - August 5 at 11:44 PM
ChemoCentryx Reports Second Quarter 2019 Financial Results and Recent HighlightsChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - August 5 at 11:44 PM
ChemoCentryx (CCXI) Reports Q2 Loss, Lags Revenue EstimatesChemoCentryx (CCXI) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 5 at 11:44 PM
ChemoCentryx to Present at the Canaccord Genuity 39th Annual Growth ConferenceChemoCentryx to Present at the Canaccord Genuity 39th Annual Growth Conference
finance.yahoo.com - August 1 at 8:58 AM
ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019 - GlobeNewswireChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019 - GlobeNewswire
globenewswire.com - August 1 at 12:00 AM
ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 201ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 201
www.nasdaq.com - July 31 at 9:15 AM
ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019
finance.yahoo.com - July 31 at 9:14 AM
The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint - BenzingaThe Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint - Benzinga
www.benzinga.com - July 26 at 7:47 AM
InflaRx downdraft engulfs ChemoCentryx, down 28% premarket - ChemoCentryx, Inc. (NASDAQ:CCXI) - Seeking AlphaInflaRx downdraft engulfs ChemoCentryx, down 28% premarket - ChemoCentryx, Inc. (NASDAQ:CCXI) - Seeking Alpha
seekingalpha.com - June 6 at 7:12 PM
Why ChemoCentryx Shares Crashed 19.1% Today - The Motley FoolWhy ChemoCentryx Shares Crashed 19.1% Today - The Motley Fool
www.fool.com - June 6 at 8:19 AM
SCYNEXIS and ReWalk Robotics among healthcare gainers; Stellar Biotechnologies and ChemoCentryx among losers - Seeking AlphaSCYNEXIS and ReWalk Robotics among healthcare gainers; Stellar Biotechnologies and ChemoCentryx among losers - Seeking Alpha
seekingalpha.com - June 5 at 7:00 PM
UPDATE: ChemoCentryx (CCXI) PT Lowered to $14 at Canaccord Genuity, Analyst Says Weakness Overdone - StreetInsider.comUPDATE: ChemoCentryx (CCXI) PT Lowered to $14 at Canaccord Genuity, Analyst Says Weakness Overdone - StreetInsider.com
www.streetinsider.com - June 5 at 7:00 PM
Why ChemoCentryx Shares Crashed 19.1% TodayWhy ChemoCentryx Shares Crashed 19.1% Today
www.fool.com - June 5 at 4:46 PM
ChemoCentryx And Aurinia In Focal Segmental Glomerulosclerosis: Strength In Numbers - Seeking AlphaChemoCentryx And Aurinia In Focal Segmental Glomerulosclerosis: Strength In Numbers - Seeking Alpha
seekingalpha.com - May 23 at 7:28 PM
ChemoCentryx (CCXI) Moves to Buy: Rationale Behind the UpgradeChemoCentryx (CCXI) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - May 21 at 6:32 AM
Hedge Funds Have Never Been More Bullish On ChemoCentryx Inc (CCXI) - Yahoo FinanceHedge Funds Have Never Been More Bullish On ChemoCentryx Inc (CCXI) - Yahoo Finance
finance.yahoo.com - May 9 at 7:48 PM
Hedge Funds Have Never Been More Bullish On ChemoCentryx Inc (CCXI)Hedge Funds Have Never Been More Bullish On ChemoCentryx Inc (CCXI)
finance.yahoo.com - May 9 at 7:48 PM
Edited Transcript of CCXI earnings conference call or presentation 6-May-19 9:00pm GMT - Yahoo FinanceEdited Transcript of CCXI earnings conference call or presentation 6-May-19 9:00pm GMT - Yahoo Finance
finance.yahoo.com - May 7 at 7:03 PM
ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates - NasdaqChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq
www.nasdaq.com - May 7 at 7:03 PM
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q1 2019 Results - Earnings Call Transcript - Seeking AlphaChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 7 at 8:22 AM
Edited Transcript of CCXI earnings conference call or presentation 6-May-19 9:00pm GMTEdited Transcript of CCXI earnings conference call or presentation 6-May-19 9:00pm GMT
finance.yahoo.com - May 7 at 8:22 AM
ChemoCentryx Inc (CCXI) Q1 2019 Earnings Call TranscriptChemoCentryx Inc (CCXI) Q1 2019 Earnings Call Transcript
www.fool.com - May 7 at 2:06 AM
ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights - GlobeNewswireChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights - GlobeNewswire
www.globenewswire.com - May 6 at 7:42 PM
ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue EstimatesChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 6 at 7:42 PM
ChemoCentryx to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 6, 2019 - GlobeNewswireChemoCentryx to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 6, 2019 - GlobeNewswire
www.globenewswire.com - April 29 at 6:45 PM
ChemoCentryx to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 6, 2019ChemoCentryx to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 6, 2019
finance.yahoo.com - April 29 at 6:45 PM
Report: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners — New Horizons, Emerging Trends, and Upcoming Developments - GlobeNewswireReport: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners — New Horizons, Emerging Trends, and Upcoming Developments - GlobeNewswire
globenewswire.com - April 16 at 8:27 AM
ChemoCentryx to Present at the H.C. Wainwright Global Life Sciences ConferenceChemoCentryx to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 2 at 8:35 AM
Form 8-K ChemoCentryx, Inc. For: Mar 27 - StreetInsider.comForm 8-K ChemoCentryx, Inc. For: Mar 27 - StreetInsider.com
www.streetinsider.com - March 28 at 7:29 PM
ChemoCentryx (CCXI) Names Rita Jain MD to Board - StreetInsider.comChemoCentryx (CCXI) Names Rita Jain MD to Board - StreetInsider.com
www.streetinsider.com - March 28 at 7:29 PM
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: Accumulation/Distribution

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel